In vitro diagnostic platforms are evolving rapidly around nucleic acid testing, multiplexed formats, automation and demand for point-of-care technology. While platform value is often dominated by reagents, a full grasp of system (hardware, software and consumables) architecture and performance is critical to market success.
We fully understand the development process needed to deliver market-leading diagnostic systems.
Ximedica offers customized solutions for biotechnology devices throughout the design process. Our technical expertise and passion for human-centric design lead the industry in speed-to-market efficiency.